Dire shortages of two critical drugs — shortfalls that have threatened the lives and care of thousands of cancer patients — should be resolved within weeks, federal drug officials said.
The two drugs are doxorubicin and methotrexate, and in both cases supplies in the United States are being bolstered by shipments from abroad. Shortages of scores of other drugs continue.
“We’re not out of the woods,” said Dr. Sandra L. Kweder of the Food and Drug Administration’s drug center. “But these two particular shortages have been very, very upsetting to patients and to us.”
Read the full story: http://hcp.lv/y4wzkd
Source: The New York Times